-Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today reported unaudited
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced it has made key advances in developing NRX-101 to treat Chronic Pain. The Company has
Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help
PHOENIX — Postal worker Eugene Gates Jr. was delivering mail in the suffocating Dallas heat this summer when he collapsed in a homeowner’s yard and
When evidence-based firearm injury prevention policies such as extreme risk protection orders are implemented properly, they can play a significant role in preventing gun-related injuries
As per Revance, Daxxify should be available at the beginning of 2024. Image credit: Shutterstock/Elnur. Revance Therapeutics has entered the cervical dystonia treatment arena after
A new American Heart Association scientific statement highlights evidence that supports shared decision-making, a term that describes the process of ensuring patients have the knowledge
Smoke permeates everything and impacts everyone. The visible stew of carbon and particulates typically from emission sources travels in the air, shrouds buildings, suffocates birds,